>Q8L163 Kojibiose phosphorylase (EC 2.4.1.230)
MVKHMFLEDVNNLISDDKWLIFQNEYNTEVNPRYETLFTLTNGYMGVRGTFEEGSEGERS
GNFIAGIFDKSDAQVREIVNAQNWLRIKLYVEGEELSLDKCQLIEFKRILDMKKGILFRS
MLIKDSKDRITRIEGYRFISRSDLHRSAIKLFVTPVNYSGVVGIESIIDGTVLNSADSPK
HRVKHLKVADNSSLNKSGVYLETATIDDDIRIATGSAVRLYHYEDKEKNNIAKFKRFLPL
GEMSIEYFEFDGTENKTVVIDKFIITYTSRDVKKGLLKSTVEKELFAFAGEGIDKELQRH
IEVYEELWSVADINIEGDEEADKALRFNIFHLMSSVNENDPMVSIAAKALHGEGYKGHVF
WDTEIFMLPFFIYVHPKAAKTLLMYRYNMLDAARKNAALNGYKGAQYPWESADTGEEETP
KWGFDYMGNPVRIWTGDLEHHITADIAFAVWEYFRATEDIEFMLNYGAEVIFETARFWVS
RCEYVKELDRYEINNVIGPDEFHEHVDNNAYTDYLAKWNIKKGLELINMLKEKYPEHYHA
ISNKKCLTNEEMEKWKEVEEKIYIPYDKDKKLIEQFEGYFDKKDYVIDKFDENNMPIWPE
GVDITKLGDTQLIKQADVVMLMLLLGEEFDEETKRINYEYYEKRTMHKSSLGPSMYAIMG
LKVGDHKNAYQSFMRSANVDLVDNQGNTKEGLHAASAGGTWQVVVFGFGGMEIDKEGALN
INSWLPEKWDKLSYKVFWKGNLIEVIVTKQEVTVKKLKGKGNIKVKVKGKELTIE
>Q8RBL8 Kojibiose phosphorylase (EC 2.4.1.230)
MQVIKKVEELMGDAKWLVFQEEYNNKLNGKYETLFTLTNGYMGIRGTFEEGSEGERPGSF
IAGIFNRGEAQVRELVNVQNWMRLKIYIEGEEIRLDRCELLEFQRILDMKKGVLFRKTVV
KDDKGRVTKIEGYRFVSRSNRHRSAIRFFITPLNYEGVIGVENLIEGTVLNSATHPKYRV
KHLKVVKNESICKSGIYLETATTDENKRIAVGSTLRIYNLEDINRENIAFFRRFIPLGEN
SAEYLEFKGEREKTVVVDKFAVTYTSRDVEKDLLKNAVENDLFDFVSRGFDEELEKHIAE
YDKLWSVADITIEGDEEADIALRFNIFHLMSSVNEKDPWVSIGAKGLHGEGYKGHVFWDT
EIFMLPFFIYVYPEAARTLLMYRYNMLDAARRNAALNGYKGAQYPWESADTGMEETPKWG
FDYKGNPVRIWTGDLEHHITADVAFAVWEYFRATNDIDFMLNFGAEIILETARFWASRCE
YVEELDRYEINNVIGPDEFHEHVNNNAYTNYFAKWNIKKGLEIIGELKENYPDYYYAITH
KISLTPEEVEKWKEVEKKIYIPYDKDKKLIEQFEGYFEKKDYVIEKFDENNMPVWPEGVD
VTKLGDTQLIKQADVVMLMLLMPEEFDEETKRINYEYYEKRTMHKSSLSPSMYAIMGLKV
GDHRNAYQSFIRSAKVDLADNQGNAVEGIHAASCGGTWQVAVFGFGGLEIDREGVLNINP
WLPEKWEKLSYKIFWKGSLLEVTVAKEEVSVKKLKGRETVKIKVKGKEMAL
>A4FEH4 HAD-superfamily hydrolase subfamily IA, variant 3 (EC 2.4.1.230) (EC 5.4.2.6) (Trehalose/maltose hydrolase-like predicted phosphorylase)
MRTTRAVSVVGGALLVAASAVVPVALTAAPAAETSGLCASDRGWELSTDRIDSDYTRHAF
VGNGYLSQRVPPTGSGYAATGEKTGFPLETPRFDGAFVAGLYGEGPSSQSKQPRHAIAAI
PTWSTLNVRVGDQTFGPNTPPEQISGFRQAVNLQCGVVRTSLTWTTPDGHATDLTYEVVA
DRAHPNVGAVRMRMTPRWDGPAEVSGAIDGAGARRLHPTGGKAEGGTVRVGFETDGVRAT
GTVASTLRADSAVDAEPVQQRVDGLNAEQRLGFAAQRGETYEFSKFVGVDTSVTTPDHAA
SAVRASREAADRGWDELFGEHAERWKRLWESDIRVPGRPDLQNSLRSSKYAILSSIRQDH
GFSVPPAGLSSDNYAGLIFWDTELWMYPSLLLQHPDIARSVVDYREKMLGAARANAASIG
QKGAFYPWTSADSGELAKDCHSWDPPHCLTQNHLQSDVALAAWQYFLATGDQRWLREHGW
PVLRGVAEYWAGRVTANPDGSYSINNVAGPDEYSNGVNDGVFTNAGAAVTLRNATEAAKL
LGEQAPPEWTGIADRLRIPYDPQQQVFQQYDGYGGQKIKQADAVLLQYPLEWPMPPEAAA
RTLDYYAPRTDPDGPAMTDSAHAIDAAATGEPGCTTNTYLNRSIRPFEKDPFAQFSEARG
ERAGEGAGAPTFNFLTGAGGYTQVFTHGLTGLRWRGDRAVLDPMLPPQLPGGVELTGLHW
QGRTFDVRVGEHETQVRLREGEPFTVEAPDGRHVVSRDAALTLKTRRPDLVPTDNLARCK
TASATSEEAGKYAEAAVDGNTATTWALNGAQGSATVDLGAPRRISGITPRWPETAPTGFR
LLTSVDGREFTEAAEQIPGGRLARYVRVELTGPAGPEHTGLSELEVRG
>A4XGP2 Kojibiose phosphorylase (EC 2.4.1.230)
MKLSEREWLIEQDKLEASGKFETCFALTNGYIGIRGINEEVFCEETPGTYIAGVFDKSTA
QVTELVNLPNPIGLRIYINREFLNPLKCEILEFKRVLDLKQGILYRKLRLKDVKGRITTI
EGFRFVSMNNKNLIVQKYDVVCENYSAVLNVESFIDATTVNSKDVPNDRVKHYEIDKKKD
FADGIYLGITTKDKKYKVGIASSTKVLLNNQRCYFNRFTKDLGYIITENFEVEAKQGERY
EIEKLTVLVSSREKNVGDVFETCTNKLKEFETKSAEKLLFEHIEEYKRLWDVANIDIVGD
EVANKSVKFNIFHLISMANPEDEHVSLGAKGLHGEGYKGHVFWDTEIFMLPFYIYTNPAA
AKAMLMYRYNLLDAARENARKNGYKGAQFPWESADTGEEETPKWGYDYLGNPVRIWTGDI
EYHISADIAYAVMNYVRATDDIDFLLNYGSEIIIETARFWASICKYNKEKGRYEINDVIG
PDEFHEHCNNNAYTNYLAKWNLLKASELCNLLLEKYPKYFEKLSKKINLSDEEPFVWQEI
ASKIYIPYHPDKKLIEQFEGYFNLKDFVIKEYDQNNMPVWPEGVELDKLNNYQLIKQADV
VMLLYLLGEEFDDQTKKINYDYYEKRTMHKSSLSPSIYALMGVRVGETNRAYINFMRTAL
TDLEDNQGNTHLGIHAASLGGTWQALVFGFGGISIEKDDVLSVNPWLPEKWESLKFSIWW
KGNLLDFKITKDNVEVKKRVEKGNVKLKIKGQEAII
>B2J166 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MQTKDRSRHFIYTDWILIETQFDPDQLQSKETVFTIGNGYLGTRGSFEEGYPHSLPATFI
NGVYDDVPVVYTELVNCPDWLPLIVIVNGDRFRLDQGEILSYDRQLDLRQGLVIRALRWR
SPSGNTIDISFERFASLADPHVLALRCHLTPIDFDGLIEVQASINGYPENQGFNHWEGLD
QGKTDQGIWLQRRTRHSRIELGMGAKVTILGAEASLQVNTAPGYPTLSTTFLAKAQQVVT
VEKLVTVFTSREIDTPVSAAQEKLAHLPDYVTLQKANQQAWDKVWQQSDILIEGDSTAAF
AVRYNVFQLLIAGARHDDRVSIPAKTLSGFGYRGHIFWDTEIFMLPLFIFTQPAIARNLL
TYRWHTLPGARRKAAHYGYKGAMFAWESADTGDEVTPRWALGNDFYGEDVRIWCRDREIH
INADIPYAAWNYWQTTGDDEWMQKCGAEIILDTAIFWASRVEFNPERQQYEIRGVIGVDE
YHELVHNNAFTNRMAQWHLEKAIAVYNWLVQKFPEQARELEEKLQLTVQDRSHWQDIINK
ILFLYDPSTELIEQCEGFFQLEDINLADYEPRDRSMQPILGVEKINKYQVIKQPDILMLL
YLMRESADFPYSEKALQANWDYYAPRTDITYGSSLGPAVHAILASDLGKSIEAYEVFLHA
LMVDLEDNRGNTSDGIHGASAGGIWQAVIFGFGGIQITENGPVANPHLPDGWTRLKFKLH
WGDKWHDFDLRKGPVRQDITRQLEYLQLSLSPNPPSNEAGGILRLRSEGGQGAGERRQDS
EALASPRASAEGKSYSSLSVSSSPIPNPQSPNIQGFIFDLDGVLTDTAELHYLAWKKLAD
EEGIPFNSQDNEALRGVSRRASLMLIVGDRPYTEAQIQEMMERKNSYYMELIQNMTSKDL
LPGAIAFLDELRQAGIKIGIGSASKNARTVIKRLGIADKVDAIADGYSVQQPKPAPDLFL
YSAKQLGLEPAQSIVVEDAAAGIEAALAAGMWAVGLGPVERVGAAHVVLPSLEGIKWADL
RAKLSDIARQKHSGTSK
>Q3M6M9 HAD-superfamily hydrolase subfamily IA, variant 3 (EC 2.4.1.230) (EC 5.4.2.6)
MNTKCPSRDFTYQDWILTETRFNPEQLHSRSTVFTIGNGYLGTRGSLEEGHARGLPATFI
HGVYDDVPVVYTELANCPDWLPMIIAINGDRFRMDQGEILQYERKLDVSQGLLSRSLRWR
SPSGSIIDIHFERFASLADHHILGQRCQITAHDGDCLVEIQASINGYAENQGFNHWEGID
QGKTEPGIWLQSRTRGTQIEIGMAAKMTISGVEAALQVSIVPGYPTISASFLAKSQQTIT
VEKLVTVFTSREVNKPVTAAQEKLAQLPDYTTLLTANKQAWDEVWQKSDIYIEGDPTAAF
AVRYNLFQLLIAAPYHDEKVSIPAKTLSGFGYRGHIFWDTEIFILPFFTFTQPALARNLL
SYRHHTINGARRKATHYGFKGAMYAWESGDTGDEVTPRWALPDNYYGEDVRIWCRDREIH
NSADIAYAVWQYWQATSDDVWMRDYGAEIILDAAIFWSSRVEYNSQGDRYEIRGVIGTDE
YHEFVHNNTFTNRMVQWHLEKALKVADWLRHTFPEGAKELEEKLQLTPELETHWQDIIKK
ICIFYDSSTGLIEQFEGFFQLKDINLEDYEPRQRSMQAILGIETTNQHQVLKQPDVLMLL
YLMRLSAEFPYNEKALKSNWDYYAPRTDITYGSSLGPAIHGILASDLGKSATAYERFMQA
LMVDLEDSRGNTNDGIHGASAGGIWQAVIFGFGGIQLTEQGPIANPHLPPNWTRLKFQLH
WRGQWYPFDLPGGVGIGDWGLGTGGVTSTQSPTPHTHSPDIRGFIFDLDGVLTDTAEYHY
LGWQRLADEEGIPFNRKANEALRGVSRRESLMRIIGDRPYSEAQIQEMMERKNCYYVELI
EHITPKDLLPGAIALLDELRQAGIKLGIGSASKNAHTVIERLGLADKVDAIADGYSVQKP
KPAPDLFLFAAHQLGLEPKQCVVVEDAAAGVEAALAGGMWAVGLGPVERVGAAHVVLPSL
AGVTWTDLRTKLNEAAGV
>F4LNL6 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MTDTMKLVRRGYSAADAARSETLFTVANGTFGLRGDYEERAGCFHKGTYINGFFDSEPIV
YGESAFGYAKEHQTLLNVPDPKNVELTVNGHPFSLDSGTVASFSQTLDFRSGLMTRLVDW
IAPDGTCVRIRSERLVPFTRSTCAAIRYDVTVTGHAGDSGHADDSGQTGDRQPVTVRIES
AVDASVRNLSAEDDPRVGAKFSSAPLLIDRLSAVPAETDGFDVVSFGAHTRNSGLLLAGT
VLSRYSVFEAGGAHTADAVDVCDATEVAAEAEFTDSGECSVCGGRGCIARTFSLAAGQSV
RLEKFISYDTARRSDSASNKKQSGSRNGEPQDGTQTGEQDAPLAAFAMVHASEAASAGFP
ALCREQRAYLDDFWRTAAVSIGADSESERAVRFSLFHLLQSAGKDGRTSIAAKGLTAEGY
EGHFFWDSEAYVCPVFTYLKPSVAASLLRFRIGTLPAARERAAQMNAAGALFPWRTIDGA
ETSAYFPAGTAQYHINADIMFALNRLLTAVPGGAGIPERDTAELAAETARMWMSLGSYIP
EKGGRFCINEVTGPDEYTACVNNNAYTNLMARENLRISAALCAHAGSGVSEAERESWLRA
ADSMYVPYDAASGVYPQDDSFMEKAPWDFAGTPPDHYPLLLHYHPLVIYRYRVLKQPDLV
LAQFLLPDQFSLAEKIRNFRFYEPYTTGDSSLSHCIQSIMACEIGDGDKAERYFRRTVAM
DIADEHGNTRDGIHTACMAGSWMALVYGFAGFRDYGGKWRFAPQLPRSWTSLSFSLLLRG
QRLTVEILPDSVTYSLGSPDAAERPPESASSFIPALSFFHRNRAVTLRCGESRSFSLRSE
LKAVLCDLDGVITDTAELHYQAWQKIANRYGLHFDRAVNEKLRGVSREASLELILAHNRR
ISVSSGGEEWTPERIKRAAAEKNGVYVSLLENLGPADILPGIAPLFTELRERGIKIILAS
ASANAPEVCRRLGITERFDAIVDPASVKMMKPEPDIFLAAAALAGVWHTDCVGIEDAQAG
IDALNAAGIKSVGIGAALRGADLTVCDTSLLEYRRLAELF
>F8F0C1 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MSSNDQYEWKIIENSWNKKKLGKDETLFTLANGHLGLRGDFDEPEPAFHRGTYINGFFEK
EPIVYGEIAYGYAEHHETILNLPDPKQVRLYVNETEFRLDQVQLGFYQRYLDMKHGLLVR
ELEALLPNGCSIRLKSRRIVSFSRETLGALEYQCTLLKSPENKPVSIRVECPLEALASNR
KAEKDPRVGSKFSRHPYRISSLSVDEHSAALSLETHRSGLAVGMVLHYQMVAHNDMKASY
KRSDHTIVHNWEGVLIPGGTFTLYKYFSYNMGNAGEQDVLQYQNKQVIQNALAAGYNQLV
QEQHEYLKAFWNHADILIDGDPEIQQAIRFNIFHILQSSGRSGKTSIAAKGLTGEGYEGH
YFWDTEIYVCPLFTYTKPEIARSLLEYRYAILDKARQRAHTMAEKGALFPWRTIDGEETS
AYYPAGTAQYHINADIVYAMEKYCMASGDREFLYNQAAEVAVETARLWLSLGHFGPDGKF
RIDCVTGPDEYTALVNNNAYTNLMAKNNLLFACKTLGQLQKDEPNLYKRFCERLAIQHDE
PEQWERVAHSMYIPFDAKTGIYPQDDSFMHKEPWPFDTTPRDKYPLLLHFHPLVIYRHQV
LKQPDLVLAQFLLSEQFTLAEKIRNYWFYEKLTTGDSSLSHCIQSIMAAEIGDETKAYDY
FLKTVRMDLDDVHGNSQDGIHTAAMAGSWLSIIYGFAGFRDRPRQGTDVRYSFNPRLPAQ
WKRLVVSLQLEDYILKVDVGRHVVQYSLLEKDSETKLAALAVQSKDEHTDLKGQSAGELR
GLPIVHRNQLLALYPGDSVTISLKPVLRAVMFDLDGVITDTARLHFKAWKRLTDEQGWSF
DEKLNENLKGISRIGSLEIILNYNKVSLTPEKKHLFAERKNSYYNELLVDLGPQDILPGI
QELLMELGKKGVKRMIASASKNALRIINQLQLGPIPGPYFEGIVDPDSVTCGKPDPELFL
QASERANVDPRDCIGIEDAQAGIDAIKAAGMIAIGVGQGLKHADKTIHDTRELSYSFLEK
VFERY
>G2KUV7 Uncharacterized glycosyl hydrolase yvdK (EC 2.4.1.230) (EC 2.4.1.8)
MLALKLSIRKMKEVESLMKRIFEVDPWKVTSHDLNPEDKRLQESMTSLGNEYMGMRGMFE
EVYSGDTHQGIYVGGVWFPDKTRVGWWKNGYPLYFGKAINALNYVKADIYVDGNQVDLAK
NDVTDFEVSLDMKNGVLNRTFTVFGVTFKITRLVSAAVKELADIHYELSSADGQTHTIRF
DASIDADVVNEDSNYDEKFWQVLDAGNETNSSFIATQTIENPFGVPQFTVVARQSFVGGE
KHGANRSEKEVTDNFDIEVPAKGSVSFEKRVIVTTSRDYDSLAQVIKAGETLTADLAAQK
YDDIYTAHAQEWANRWEKADVKIEGDDAAQQGIRFNLFQLFSTYYGNDPRLNIGPKGFTG
EKYGGATYWDTEAFAIPVYLGVADPSVTRSLLQYRFDQLDGAFHNAKEQGLKGALYPMVT
FDGIESHNEWEITFEEIHRNSTIAYAIYNYTNITGDHSWLDGDGAQVLYNIARFWADRVH
YSARNDKYMIHGVTGPNEYENNVNNNFYTNWMAKWVLQYSLEHYGEINADEKAKLALTDE
ELAKWQEIVDKMYLPEADVETKTGKKHIFVQHDTFLDKDLTPIADMPQDIRPINQHWSWD
RILRSPYIKQADTLQAMFYFPDAFTEEEKRNNFEFYEPFTVHESSLSPSVHSILAADLRM
EDKAVELYERAARLDLDNYNNDTSDGLHITAMTGSWLAIVQGFAGMRVRDGKLYLKPFLP
KKWTKYAFRLVFRGHVLEVSVDGQGAHVDLISGEPLVINLSGQDVELTK
>C9Y581 Uncharacterized glycosyl hydrolase ycjT (EC 2.4.1.230) (EC 2.4.1.8)
MADPAAGGGHLSGGRNREVCRAMNPLTTLVEARFDPHYHNKYATLMAAGNGALGVRATHE
EAYATQTRGMFFAGLYHRAGEGETTELVNLPDLVGMDIELNGEIFSLLGGEILRYRRELC
FASGELARIVEWRSAQGQRFTIASTRFVSAARRGLFCLRLAITAHDGAATVRVATGIDAT
QTNSGRQHLAERELRVFDNCYLQGRYRTLDNASDVTLGCACRVSPQAQVSFSAKNRRLLQ
HSQQTLATGECFTLEKCAWVSASPDAPDDGAASVALRALRECATVGYDALLAESSEARRV
WWRHARVEVDSENEADQQALDFALYHLHAMTPRHDERSSIAAKGLTGEGYKGHVFWDTEV
FLLPFHLHTAPSVARQLLRYRWLNLTGAKRKAARGGWQGALFPWESARSGEEETPEFAAI
NIRTGQRQKVASALAEHHLVADIAWAVATYWQATGDDAFMAKEGRALLEDTARFWLSRAQ
DVNGRLELHDVIGPDEYTEHINNNAYTSYLAHYNVALARENHRRLGVPDDAFTAQCEDFL
ARLYLPVARADGVIPQDDTFFSKPTIDLTRYRASAGSQSVLLDYSRAEVNEMQILKQADV
VMLLYMLPWRFDNATAAANLDYYEPRTIHDSSLSKAIHGIVAARCGRRDEAYRFWRAGCD
IDLGDAPHSSDDGIHAAATGAIWLGAVQGFAGISVKAGELHVTPSLPQQWRRLAFPFCWQ
GRQLHLVITHDALTVRSDGAVRLFINDTAVDVEGERTFCLSADVCKEATCNRMQ
>K9X9H4 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MDYSGWNIFETQFDPAELHHKETLFTLGNGYLGTRGSFEEGYPNASAATMINGVYDDVPV
MHTELVNCPDWLPLTVYIGSDRFCLNQGEILEYQRQLDLRWGIVSRDVLWRSPSGHTVKF
HFERMISMADDHALVLYCQITPIDFTGAIALEASINGNIDNHGVKHWDWLEQGGSNNQAW
LHQRCIHSEIELGMAFQLACSEATPVKFTGNPGTPTLTTSFQAQPGKTVTLEKIVTVFTS
LEVNQPVAAAQERLASLPSYSTLLAAHGAVWDELWQDCDIAIAGDSTAQVAVRYNLFQLL
AAAPRHNNRVSIPAKTLSGFAYRGHVFWDTEVFIVPFFTFTQPQIARNLLSYRYHTLEGA
RRKAQAAGYEGAMFAWESANTGDEVTPRWVFGPDGEPVRIWCGDIEVHINSDIAYAVWHY
WQATRDDDWMQREGAEIILDTAVFWGSRVEWNSDRQRYEIRDVIGPDENHERVDNNTFTN
RMAQWHLEIALTVYDWLQQHYPEKATELAQKLDIRPERIKRWSHIIRYMLVAQPTDTEVI
EQFEGFFDLEDIDWQDYQWRTQSMQAILGVEGTNEKQILKQPDILMLLYLLRDQPLRTEM
SAQQRRQLLQANWNYYTPRTDHTYGSSLGPAIHAILACELDDPAAAYEHFMRAALVDIKD
VRGNAAEGVHAASAGGVWQAVIAGFAGVRLTEAGPVVERSHLPSNWTRLQFQLQWQQQWY
KFDISPDAVLMTTHKPEASETYSEELNQVRPNRTLSDRCPITPLRGVIFDLDGVLTDTSE
YHYLAWKQLADEIGIAFDRQANEQMRGLSRRDSLLHMLGDRAVSEAQLQEMMVRKNSYYE
QLIHNLTPADLLPGALDLLDELQAADIKVAIGSSSKNARLVCQRLGIAERLNAIADGYSV
EHHKPAPDVFLYAAQQLGLQPHECLVVEDAGSGVAAGLAAGMWVLGLGPVERVGHAHLVR
DNLAGLEWQQLVVDLEQSQMLVCRD
>K9V0C6 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MDIKGLNSDFIYTDWTLIETRFPPEQIHHRETVFTIGNGYLGTRGTFEEGYSRSVAATMV
NGVYDDVPIVYTELANCPDWLPLAIVVEGDRFRMERGEIISYERQLDLRWGVLQRRVRWR
SPNGKTVDLEFERFASLADEHVLVQRCQITPVDFDGLIEVQSSINGYPENQGFNHWELLD
QGKRKEGLWLNLRTRGSRISLGMATNLVVRDTEANLQVSNPPGYPTFTASYQGITGQTVT
VEKFITVYTSREVTDPVTAACEKLGELSSYSQLLTAQKQAWNAAWHNSDIKIEGNTRDAL
AVRYNIFQLLISATAHNDKVSVPAKTLSGFGYRGHIFWDTEIFILPFFTFTQPELARNLL
SYRYHTLPGARRKAIHYGYKGAMYSWESADTGDEVTPRWLPPNDPYGDDIRIWCRDREIH
ISADIAYAVWYYWYVTGDDGWMRDYGAEIILDTAVFWGSRVEYNTKSEHYEIRGVIGADE
YHELENNNAFTNRMVQWHLEKAIALQDWLRENYPDKAKELEEKLQLSLSRRLRWQDIIAN
LWIPYNAATGMIEQSDGFFQLQDINLEDYEPRTKSMQTILTIEGANKCQVLKQPDVLMLL
YLMRESHDFPYTLEVLEKNWDYYAPRTDITYGSSLGPAIHAILASDLGKTAEAYTRFLQA
ALVDIEDVRGNADDGVHGASAGGVWQAVVFGFGGIQLTEAGPVATPHLPPEWQRLQFKVY
WRGKWHEFDLKATGETMENNANQIQGVIFDLDGVLTDTAEYHYRGWQKLADEEGLSFSRE
ANENLRGVSRRDSLLYITGDKAYSEAQIQEMMERKNRYYLESIQDISPIDLLPGALDLLK
ELKADGIKIAIGSASKNAQMVVEKLGINSYIDVLADGFSVEKPKPEPDLFLFAAKELGLI
PSQCIVVEDAAAGVEAALAAKMRAVGLGPAERVGTATVVLPSLAGVNWQDLQGKLTK
>K9Q916 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MNTKSITDNFIYTDWTLTETQFDPDQIHSRETIFTIGNGYLGTRGSFERDYPRELPATFI
HGVYDDVPVVYTELANCPDWLPMVVTIDGDRFRLNEGEITHYERVLDVRHGLLNRSLRWR
TPTGKTIDIRFQRFASLADQHILCQRCELTPLDFDGLIEVQGSINGYPENQGFNHWVDLD
QGKTEHGIWFQSRTRGSRITIGMAAKMTVLGTESSIQVNTAPGYPSLNATFLTKSQQTVT
VEKFVTVFTSREIETPIKAAQEKLAEISDYETLRNTHTQAWDAVWQQSDILLEGDNTAAF
AIRYNIFQLLIAAPRYDDKVSIPAKTLSGFGYRGHVFWDTEIFILPFFTFTQPAIARNLL
TYRYHTLPGARRKALHSGYKGAMYAWESADTGDEVTPRWSLPNDFYGEDVRIWCRDREIH
ISADIAYAVWYYWLATGDDEWLRDYGAEIVLDTAIFWGSRVEYNSEQQRYEIRAVIGADE
YHELVHNNTFTNRMVQWHLEKAIFIDDWLRQNFPELAAELAKQLQLTAEVRSHWQDIIAK
IWIPYDPETGLIEQFEGFFQLQDINLDEYEPRQRSIQAILGIEEGNKRQVLKQPDVLMLL
YLMRESADFPYNPKSLQANWDYYAPRTDITYGSSLGPAIHSILASDVGESVRAYKRFMQA
AMVDLEDSRGNTNDGIHGASAGGVWQAVVFGFGGIQLTENGPVANPHLPSHWTRLKFKLH
WRGEWHEFDLQPQGGQERMTDIRGVIFDLDGVLTDTAEYHYQAWQRLADEEGIPFSRAAN
EALRGVSRRESLMLIIGDRKYSEAQIQEMMERKNGYYVELIHHVTPKDLLPGAIALLDEL
RQAGIKTAIGSASKNAHTVVELLGIADKVDAIADGYSVQKPKPAPDLFLYAAKELGLQPK
QCVVVEDAAAGVEAALAGDMWTVGLGPVERVGAADVVLPSLAGVKWADIQAKLSEKVLSS
E
>K9ZK28 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
METKNDFTYTDWILNEIQFESEELNARETIFTIGNGYLGTRGTFEESHPLTLSATFIHGI
YDAVPVVYTELANCPDWLPLVVIIDGERFRLDQGKILEYNRKLDLRQGLLSRSLRWRSPS
GKTINITFERFASLADHHVLGQRCQLEAVDFHGLIEIQGSINGYPENKGFNHWEGLEQGK
IDKGFWFHSRTRTSQIDIGMAARMTISGIDAALQVNTAPGYPSISATFLIEPHQTVTIEK
IVTVFTSRDVEQPVAAAQEKLADLGDYITLRNANEQAWAEVWDKSDIVIEGDNKAAFAVR
YNLFQLLIAAPRDNEKVSIPAKTLSGFGYHGHIFWDTEIFILPFFTFTQPVTARNLLSYR
YHSLDGARRKASHYGYQGAMYAWESAVTGDEVTPRWALLSDFYAEDIRIWCRDREIHISA
VIAYSVWYYWRVTGDDEWMRDYGAEIILDTAIFWESRVEFNSQAERYEIRGVIGADEYHE
LVHNNTFTNRLVQWHLEKACIIYDWLQRSFPERSAELAEKLQLTAKIRDNWQDIINKIWI
LYNPETELIEQCEGFFQLEDINLADYEPRQKSMQAILGIEGANKRQVLKQPDVLMLLYLM
RESADFPYSEKILQVNWDYYAPRTDISYGSSLGPAIHAILAADLGKTQEAYERFMQAAMV
DLEDRRGNTNEGIHGASAGGIWQAVVFGFGGIQFTDNQPVAHPHLPPGWTRLKFKLYCRG
KWYEFDLRQELGTGEGRGYLAPTIRGIIFDLDGVLTNTAEYHYLAWQKLADEEGIPFNRQ
ANEELRGISRRASLMLIIGDKRYSEVQIQEMMERKNDYYVESIQDITPKDLLPGAVSFLD
DLRQAGLKIALGSASKNARVVIEKLGIADKIDAIADGYSVQKPKPAPDLFIFAAQQLGLP
AKQCVVFEDAAAGVEAALAAGMWAVGIGPPERVGAAHIILPNLAGMTWEKLQGKFRDIAL
QKRKNSGVRSQESECL
>K9PJD6 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MDIKGNSRHFIFTDWILIETQFDPEQFHSKETVFTIGNGYLGTRGSFEEGYSRGSPATFI
HGVYDDVPVVYTELVNCPDWLPLVVIINGDRFRMDQGEILNYHRQLDLYQGLLTRSICWR
SPSGNTIDIQFERFASLADQHILGQRLQLKPLNFDGLIEIQASINGYPENVGFNHWQELE
QGKTESGIWLHRRTRSSQIDIGMAAKMGISGVDTSWQISSAPGYPTFTTTFLANAGQTVI
VEKVVTVFTSRDINTPVIAAQNKLALLPDYDTLFDAHEQAWNQVWKSNDILIEGDRTAAF
AVRYNLFQLLIAAPKYDDKVSIPAKTLSGFGYHGHIFWDTEIFILPFFIYTQPAIARNLI
SYRYHTLNGARRKATHYGYKGAMYAWESAVTGDEVTPRWSLPSDFYGEDVRIWCRDREIH
ISADIAYGVWYYWQATGDDEWMRDCGAEMILDTAIFWGSRVEFNPQFERYEIRGVIGADE
YHEFVHNNTFTNRLVQWHLEKALLVYDWLSHNFPEQATQLEQKLHLTSKQRMRWQDIISN
IWISSERTTGLIEQFEGFFQLQDINLQDYEPRTRSIQAILGIESTNKHQVLKQPDVLMLL
YLMRQSADFPYNQKLLQTNWDYYAPRTDITYGSSLGPAIHAILAADLGKLTEAYERFMQA
AMVDIQDLRGNTSDGIHAASAGGVWQAIVFGFGGIQFTEKGPVANPHLPPGWTRLKFQLQ
WRGQLHEFDLHEELGQGAGGRGHTSAPLSVQGAGGDKFLVPNPQSPIPSPQSLLTERSRS
AVPNPQSPIPSKAVIFDLDGVLTDTAEYHYLAWQRLADEEGIPFNREANEALRGVSRRGS
LMAIIGDRQYSEAQIQEMMERKNRYYVESIQNITTKDLLPGAIALLDELRQLGIKTAIGS
ASKNAHEVVERLGIADKVDAIADGYSVQQPKPAPDLFLYAANLLGVPPAQCVVIEDAATG
VEAALSAGMWAVGLGPPERVGAAHVVLPSLAGIKWADIIAKIS
>K9PPC9 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MIKASDHYLQYNQQMIASTDWNVIETNFDPAQLHHKETVFTLSNGYLGTRGTFEEGYPRD
SPATLIHGVYDDVAITHTELVNCPNWLPLVVTVAGDRFSMDSGEILHYERRLDLRLGIVS
RDIRWRSPQGHTLDLHFERFASLADQHVLAIRCQITSLDFAGDISIEVGFDEEVDNQGVK
HWKTLNQGGVEQIIWLYHQTRRSEIKLGMAAKLVVEGDDAAAVRLENADVSPSLTTTCHC
VPGKTVTVEKIVTVFTSRETEIPIAAALERLADEPSYATLLAAHITAWEQVWQDSDIIIE
GDRQAQLSVRYNLFQLLAVTPRHDTHVSIPPKTLSGFAYSGHIFWDTEIFILPFLTLTQP
ALARNLLTYRYHTLPGARRKAQEAGYQGAMFAWESANTGDEVTPRWVPDAKKEGELIRIW
CGDIEVHITADVAYAVWHYWQYTNDDDWMRDYGAEIILDTAIFWESRVQWNQQRQCYDIL
DVIGPDENHDRVDNNAFTNLMVQWHLQSALALWDWLKQAYPETAAQLAQKINLTTESLHL
WAEIQERLFINQDAETGLIEQFDGFFQLEDINFADYEPRHKSLQGLLGIEATSQKQILKQ
PDVLMLLYLLRQRYDHKTLESNWEYYNQRTDHTYGSSLGPAIHAILACDLNQPTQAYTHF
LRSALVDLEDVRLNAAEGIHGASAGGVWQAVVFGFGGIRMTEFGPVACPNLPPTWTRLKF
RLQWHNQWYDFDLQPETTVSRPKITGVIFDLDGVLTDTSELHYLAWQQLADEEGIPFDRE
TNDRMRGLPRRETLLQILGDRPITEEQIQEMMERKNRYFLELMQNITTTDLLPGVANLLQ
ELQAAGIKVALGSSSKNAQTVIQRLDIADKLDFVADGHSVSQPKPAPDLFLFAAAQLGLS
ASQCIVVEDAAVGIEAARSAGMLAIGLGPVERVGKANLVLPSLEGVRWQELQEQITTSKK
RDSLVSVAP
>K9VVT5 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MESFGWTVIESQFDPTHLHHQETVFTLGNGYLGTRGSFEEGYPGECSTTLIHGVYDDIPV
VYTELVNCPNWLPIVITIGGETFRLDQGQTLHYQRQLDLRLGLLSREIRWRSPAGHTVDI
YFERFTSLADQHVLVQRCQVTSVDFTGEIEIQASINGEVDNQGVKHWEFVEQSITDNTLW
LHTRTLNSAIDLAIAAKLLIVDFPAEIQALRTQNCPGLGTTVQIQPGQTITLEKLVTVFT
SRDRVDPVGEALGLLNCLPSYTTVFAAHVAAWAKVWQDSDIVIEGDLKAQLAVRYNIFQL
LAVAPRHDNRVSIPAKTLSGYAYRGHIFWDTEIFIVPFLTLTQPALARNLLTYRYKTLAG
ARRKAQEAGYEGALFAWESAKTGDEVTPRWVPGPDGKIIRIWCSDIELHINNDIAYAVWH
YWQNTGDDAWMREYGAEIILDTANYWASRAEWNKERGAYEISDVIGPDEYHEKINNNAFT
NGMVQWHLQTALGVWDWLTRSDSDRATILKQQLKLNKKRFQQWAEISQNLVFNQNADTGL
IEQFDGFFDLKDVPLTEYEPRTKSMQVILGIEGANQQQVLKQPDVLMLLYLLRDRTNRQT
LQTNWDYYNPRTDHTYGSSLGPAIHAILGCELGQPEEAYKHFMRSALVDLEDVRGNANEG
IHAASAGGVWQALIFGFAGVKLTPEGPISSPHLPPGWTRLKFRLQWRNQWYEFDIQESAT
SDQQSAMISSSTSNSQLATPNIKGVIFDLDGVITDTADFHYLGWKRITDEEGIPYDWETN
EKMRGLTRRDSLLYILGDKKVSEATIQDMMERKNNYYLELIKEMTPDKLLPGVLNLLNEL
RAAGIKVALGSSSKNAHLVLQRLGIEDKFDAIADGYSVENPKPAPDLFLHAAAQLNLSPE
ECVVIEDATAGVEAALSAGMYAVGLGPVERVGDADVVLPNLEGVQWSDLLTQIAVSSQSS
DVRSLKV
>K9XJA8 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MSQAVSQFLRETTSVQAPVPSQTNNLRYTDWVLIERGFDPNQLHARETVFTIGNGYLGTR
GSFEEGYPRAMPVTLIQGVYDAVPVMYTELVNCPDWLPLTITLNDDPRRSERFRLDQGEV
LSYERRLDLRYGLLRRSIRWRSPSGKTLDLQFERFASLADPHVLGLRCLITPIDWEGAIA
VHASINGYAENQGFNHWDLLTQDQTETNFTEDLQLEPAIWLAARTRQSQIELGMAAKLII
QGVDATFQRESAPGYPTLTTSYQAAIGQTVLVEKMVTVYTSQDIEYPLKAAQSKLVTLPS
YPECWEQHKQAWKSAWHTSDVIVEGDIRAQLAIRYSVFQLLISAPWHHQQASIPAKTLSG
FGYRGHIFWDTEIFILPLFTLTQPELARRLLTYRYHTLEGARRKARSYGYKGAMYAWESA
DTGDEVTPRWALPSDPYASDIRIWCRDREIHISADIAYAIWNYWQATGDELWMRDYGAEI
ILDTAVFWMSRVEWNSQFERYELREVIGADEYHEHHVNNNAFTNRMTQWHLEKAIAVYAW
LDRTFPEQAAALAQKLEITPERRQRWQDIANHLWIPYRAETGFIEQFEGFCNLEDINLQD
YEPRTKSMQTILGIDGANKRQVLKQPDVLMLLYLMRQLQEFPYNPESLKTNWDYYAPRTD
ITYGSSLGPAIHAILAADLGDSQTAYKHFLQAALVDLENTRGNTAEGIHGACAGGAWQAI
VFGFAGIRFQDNQPIATPHLPPHWTRLAFKLHWRGTWHPFDITHSASEMNSHHPSPSPEM
HEASPTINLRGAIFDLDGVLTDTAEYHYRAWQRLADEEELPFDRQANEALRGISRRESLL
KIVGDRTYSEAQLEEMMERKNRYYQEFIDSMSLNDLLPGVRSLLTELRQQQIQIAIASAS
KNARTVIEKLNITELVDAIADGYSVERPKPAPDLFLYAANQLKLPPAECVVFEDATAGIE
AALAAGMWSVGLGPVERVGNAHVVLPNFADITWAGILSKLNQCLS
>G6FQY2 Beta-phosphoglucomutase (EC 2.4.1.230) (EC 5.4.2.6)
MDTTGRYQHLTYTDWTVRETQLEPEQFRYRETVFTIGNGYLGTRGSFEEGYSYALPATFI
HGVYDEVPIVYTELANCPDWLPFTITIDGDRFRLEKGEILSYERILDLRRGILNRSVRWR
SPNGKTIDIHFERFASLADEHVLVLRCQLTPVDFAGAIEVQASINGYPENQGFNHWEWLD
QGKTEAGIWLNLRTRSSRIQLGIATGIKILGVDASLQVTSPPGYPTLSASFLASPGQTVT
VDKFVTVFTSQHRENPVTAACEKLAQLPEYSFLLTAHTQAWEEAWQKSDIVIEGDITAQL
AVRYNLFQLLIAAPRNNDKVSIPAKTLSGFGYRGHIFWDTEIFILPFFIYTQPELARNLL
TYRYHTLPGARRKAVHYGYKGAMYAWESADSGDEVTPRWLPPNDPYGEDIRIWCRDREIH
ISADVAYAIWYYWQATNDDEWMRDYGAEIILDTAVFWGSRVEYNTKHERYEIRDVIGADE
YHEFVHNNAFTNRLVQWHLEKALYIYDWLDKNFPGKATELKDKLQLSAGRRSRWSDIITN
IWIPYDESNGLIEQFEGFFQLQDINLEDYEPRTKSIQAILGIEEGNKRQVLKQPDVLMLL
YLMRQSQESPYNPHTLQANWDYYAPRTDISYGSSLGPAIHAILASDLGKTAEAYERFMQA
ALVDLEDVRGNAHEGIHGASAGGIWQAVVLGFGGIQMGNSEPIAHPHLPPGWTRLKFKLM
WRGKWHEFDLRTGDKEIRGQGKWITTNKQPPTTMSPDIRGFIFDLDGVLTDTAEYHYLAW
QKLADEEGLPFSRDANEALRGVSRRESLLYIVGDRKYSEAQLQEMMDRKNRYYVESIQNI
SPQDLLPGVVTLLDELKQAGIKIALGSASKNARTVIEKLGIANRIDAIADGYSVQRPKPA
PDLFLYAAKQLGLEPAQSVVVEDAEAGIEAALAGGMWAIGLGPASRVGAAHIVLPSLAGV
HWSDLHAKLNELVIGNRG
>N0CVK1 Uncharacterized protein (EC 2.4.1.230) (EC 5.4.2.6)
MSLSRISVLAPLVAAALIAPLPPLPRAAAATPPPPPSSPAVPACGRTDGQDPTWALSSTR
FGESEGYDPYVGNGYLGHRVPATGTGYAATGEKTGWPLYTPRYDGAFVSGLYATDKAVSE
GREVIAALPSWTTIEVGVGNEKYGADTPAGRISRYRQTVFLSCGLVRTSLRWTTADGRAT
DLTYDVLADRSDVHTGAVRLRMTPRWSGTATVTGRLDDRGARRITLRKDGTFRALGTGVE
GAVAQTMRRGSGVVETLRPESRTAPRPTPVREGTTYTFEKYVGVDTALTSRAPADDAREA
AHRAARRGWERIFAANETAWREAWSADVLVPGDRRLQGWLRSTQYGLLASTRRGSSDSIA
PAGLTSDNYAGMIFWDAETWMFPGLLATRPELARSVVEYRYRTRDAARANAEKYGHRGLF
YPWTSASRGRIDSECQSWDPPHCLTQNHLQGDVSLAVWQYYLATGDRDWLAARGWPLLKG
IAEFWQSRATANADGSYSIKNVAGPDEYSNGVDDAVFTNAVAATALRNATRAADLLGHRP
PTGWNRVADGLRIPYDADRKVFLQYAGYNGSTIKQADTVLLMYPLEWPMEPGAAAATLDY
YAARTDPDGPAMTDSVHAIDAAAIGEPGCSTYTYLQRAVRPYLRGPYDLFSEARGDKSGA
EDPLSGFPAEDFLTGKGGFLQVFTHGLTGLRLRGDGVHLDPLLPPQLQEGVRLTGLRYRD
ATYEVEIGARTSTVRLTSGTPFTVHTAEGPRHLTSALVLPTRRPDLTPTADAARCRPATA
TSETPGLYAEAAVDGSPATSWSPDGAEGALTVDLGPHPLRITSVTPRWSDVPPASHTLET
SVDGRFWRPYLAGDTARKVRVTVVSEDPEKPAGVAELRVEAGR
